These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Double blind trial in the treatment of herpes simplex and herpes zoster with adenine arabinoside and idoxuridine.
    Author: Theodoridis A, Sivenas C, Vagena A, Capetanakis J.
    Journal: Arch Dermatol Res; 1978 Jul 28; 262(2):173-6. PubMed ID: 356754.
    Abstract:
    In a double blind trial adenine arabinoside (Vidarabine) and Idoxuridine (IDU) were tested in herpes simplex and herpes zoster infections. Adenine arabinoside covered 19 patients with HSV and 6 with HZ while IDU 19 with HSV and 6 with HZ. From the statistical analysis it was found that Vidarabine acts shorter than IDU in HSV P less than 0.01, while in HZ no significant difference P less than 0.5 was found, possibly due to the small number of patients tested.
    [Abstract] [Full Text] [Related] [New Search]